Enhanced bioavailability of probucol following the administration of solid dispersion systems of probucol-polyvinylpyrrolidone in rabbits

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 11, 2009, Pages 1880-1884

  Kubo, Yoshitada ^a   Terashima, Yuuji ^a   Yagi, Naomi ^a   Nochi, Hiromi ^b   Tamoto, Koichi ^b   Sekikawa, Hitoshi ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Bioavailability; Dissolution; Polyvinylpyrrolidone; Probucol; Rabbit; Solid dispersion system

Indexed keywords

POVIDONE; PROBUCOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DISPERSION; DISSOLUTION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; MALE; NONHUMAN; PH; SOLID DISPERSION SYSTEM; WEIGHT;

ADMINISTRATION, ORAL; ANIMALS; ANTICHOLESTEREMIC AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; MALE; POVIDONE; PROBUCOL; RABBITS; SOLUBILITY;

EID: 70350738489     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1880     Document Type: Article

References (24)

1. Wurster D. E., Taylor P. W., J. Pharm. Sci., 54, 169-175 (1965).
2. Aguiar A. J., Krc J. Jr., Kinkel A. W., Taylor P. W., J. Pharm. Sci., 56, 847-853 (1967).
3. Doluisio J. T., Fedder D. O., Manley G., Mattey T., Nightingale C., Barr W. H., J. Am. Pharm. Assoc. NS, 13, 278-280 (1973).
4. Baumont J. L., Dachet C., Buxtorf J. C., Symp. Givanni Lorenzini Found, 7, 211-217 (1980).
5. Salel A. F., Zelis R., Sodhi H. S., Price J., Mason D. T., Clin. Pharmacol. Ther., 20, 690-694 (1976).
6. Barnhart R. L., Busch S. J., Jackson R. L., J. Lipid Res., 30, 1703-1710 (1989).
7. Kuzuya M., Naito M., Funaki C., Hayashi T., Asai K., Kuzuya F., J. Lipid Res., 32, 197-204 (1991).
8. Yagi N., Terashima Y., Kenmotsu H., Sekikawa H., Takada M., Chem. Pharm. Bull., 44, 241-244 (1996).
9. Heeg J. F., Hiser M. F., Satonin D. K., Rose J. Q., J. Pharm. Sci., 73, 1758-1763 (2006).
10. Shudo J., Pongpeerapat A., Wanawongthai C., Moribe K., Yamamoto K., Biol. Pharm. Bull., 31, 321-325 (2008).
11. Pongpeerapat A., Wanawongthai C., Tozuka Y., Moribe K., Yamamoto K., Int. J. Parm., 352, 309-316 (2008).
12. Thybo P., Pedersen B. L., Hovgaard L., Holm R., Mullertz A., Pharm. Dev. Technol., 13, 375-386 (2008).
13. Sekikawa H., Fujiwara J., Naganuma T., Nakano M., Arita T., Chem. Pharm. Bull., 26, 3033-3039 (1978).
14. Simonelli A. P., Mehta S. C., Higuchi W. I., J. Pharm. Sci., 58, 538-549 (1969).
15. Kondo K., Kagami A., Tada N., Miyazima E., Ishikawa T., Nakamura H., Tachizawa H., Suzuki T., Domyaku Koka, 10, 1103-1106 (1983).
16. Maeda T., Takenaka H., Yamahira Y., Noguchi T., J. Pharm. Sci., 66, 69-73 (1977).
17. Satonin D. K., Coutant J. E., J. Chromatogr., 380, 401-406 (1986).
18. Yamaoka K., Tanigawara Y., Nakagawa T., Uno Y., J. Pharmacobiodyn., 4, 879-885 (1981).
19. Sekikawa H., Nakano M., Arita T., Chem. Pharm. Bull., 27, 1223-1230 (1979).
20. Sekikawa H., Hori R., Arita T., Ito K., Nakano M., Chem. Pharm. Bull., 26, 2489-2496 (1978).
21. Sekikawa H., Nakano M., Arita T., Chem. Pharm. Bull., 26, 118-126 (1978).
22. DiNunzio J. C., Miller D. A., Yang W., McGinity J. W., Williams R. O. 3rd, Mol. Pharm., 5, 968-980 (2008).
23. Kohri N., Yamayoshi Y., Xin H., Iseki K., Sato N., Todo S., Miyazaki K., J. Pharm. Pharmacol., 51, 159-164 (1999).
24. Heeg J. F., Tachizawa H., Nouv. Presse Med., 40, 2990-2994 (1980).